financetom
Business
financetom
/
Business
/
dentalcorp Shows Q3 Earnings Improvement On Higher Than Expected Revs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
dentalcorp Shows Q3 Earnings Improvement On Higher Than Expected Revs
Nov 6, 2025 6:53 AM

09:28 AM EST, 11/06/2025 (MT Newswires) -- dentalcorp Holdings (DNTL.TO) on Thursday said it had narrowed its net loss and comprehensive loss, and improved adjusted earnings in the third quarter on better than expected revenues.

The company's third-quarter net loss and comprehensive loss was C$4.9 million compared to net loss and comprehensive loss of $22.7 million in the corresponding year-ago quarter.

The company reported adjusted net income of $28.8 million in the third quarter, compared to $25.5 million in the year-ago quarter.

Third-quarter revenue was reported at $420.1 million, an increase of 11.9% from $375.4 million in the year-ago quarter and beating consensus estimates compiled by FactSet of $417 million.

"We delivered revenue and Adjusted EBITDA growth of approximately 12% and 14%, respectively, over the third quarter of 2024," said Dentalcorp's ( DNTCF ) Chief Executive Officer and Chairman, Graham Rosenberg. "Third quarter Adjusted EBITDA Margin expanded 30 basis points over the third quarter of 2024 to 18.7%."

On Sept. 26, the company had announced that it entered into a definitive arrangement agreement to be acquired by funds affiliated with GTCR LLC in an all-cash transaction that values the company at approximately $2.2 billion on an equity value basis and $3.3 billion on an enterprise value basis.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's C919, rival to Boeing and Airbus, makes debut display outside Asia
China's C919, rival to Boeing and Airbus, makes debut display outside Asia
Nov 17, 2025
DUBAI (Reuters) -China staged a Middle East debut for its C919 jetliner with a flying display at the Dubai Airshow on Monday, its first outside East Asia, as it showcases plans to compete with Airbus and Boeing ( BA ). The C919 aircraft, in a white livery with blue and green details, took off at around 3:30 p.m. local time...
Matter Family Office and IWP Family Office Combine to Offer One of the Most Comprehensive Family Office Solutions for Ultra-High-Net-Worth Families
Matter Family Office and IWP Family Office Combine to Offer One of the Most Comprehensive Family Office Solutions for Ultra-High-Net-Worth Families
Nov 17, 2025
Merger Expands Capabilities While Enhancing High-Touch, Generational Service https://www.youtube.com/watch?v=x7n_c5F6y48 ST. LOUIS, MO / ACCESS Newswire / November 17, 2025 / Matter Family Office and IWP Family Office announced today that they have merged, uniting two organizations with a shared commitment to serving ultra-high-net-worth families. The unified firm will continue to set the standard for an integrated, forever multi-family office that...
CC Landscaping Warehouse Plus Joins SiteOne Landscape Supply
CC Landscaping Warehouse Plus Joins SiteOne Landscape Supply
Nov 17, 2025
ROSWELL, Ga.--(BUSINESS WIRE)-- SiteOne® Landscape Supply, Inc. announced today its acquisition of CC Landscaping Warehouse Plus, a wholesale distributor of nursery products, bulk materials and landscape supplies in Bradenton, Florida. “We’re excited to welcome the talented team of CC Landscaping Warehouse to the SiteOne family,” said Doug Black, Chairman and CEO of SiteOne. “This acquisition enhances our presence in the...
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
Nov 17, 2025
Acquisition provides highly differentiated clinical-stage treatment for prostate cancer, building on Johnson & Johnson’s nearly two decades of innovation in the disease area Lead asset shows potential to overcome common types of resistance to treatment in prostate cancer with a precision tumor cell-killing approach Includes novel technology platform capable of developing the next generation of highly targeted oral treatments for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved